Skip to main content
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
59.00
+1.65 (2.88%)
At close: Jun 26, 2026, 4:00 PM EDT
58.60
-0.40 (-0.68%)
After-hours: Jun 26, 2026, 7:59 PM EDT

BioMarin Pharmaceutical Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Voxzogo
926.39M 861.39M 833.19M 795.70M 734.60M 672.30M 605.50M 534.90M
Voxzogo Growth
26.11% 28.13% 37.60% 48.76% 56.36% 71.99% 91.49% 125.41%
Naglazyme
484.87M 474.87M 484.77M 487.90M 479.50M 467.80M 444.80M 402.90M
Naglazyme Growth
1.12% 1.51% 8.99% 21.10% 14.09% 10.72% 7.67% -8.18%
Palynziq
432.94M 407.94M 389.54M 371.90M 354.60M 342.40M 330.70M 317.30M
Palynziq Growth
22.09% 19.14% 17.79% 17.21% 16.64% 18.68% 19.91% 20.88%
Aldurazyme
208.44M 198.44M 215.44M 197.60M 183.90M 187.60M 130.40M 132.10M
Aldurazyme Growth
13.34% 5.78% 65.21% 49.58% 40.17% 48.65% -7.78% -4.55%
Brineura
185.69M 184.69M 173.69M 170.30M 169.30M 164.90M 168.90M 161.70M
Brineura Growth
9.68% 12.00% 2.84% 5.32% 4.64% 2.55% 7.17% 2.86%
Kuvan
99.03M 104.03M 108.13M 109.70M 120.60M 129.30M 144.10M 166.10M
Kuvan Growth
-17.88% -19.54% -24.96% -33.96% -33.26% -34.56% -31.93% -24.05%
Royalty and Other
53.49M 49.93M 46.51M 43.98M 44.48M 45.90M 47.10M 47.80M
Royalty and Other Growth
20.27% 8.78% -1.26% -7.99% -4.96% 0.44% 5.61% -4.59%
Roctavian
36.20M 34.20M 38.40M 36.60M 26.40M 18.10M 11.70M 4.30M
Roctavian Growth
37.12% 88.94% 228.20% 751.16% 654.29% 2,162.50% - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.